Yuling Zhou

1.1k total citations
51 papers, 599 citations indexed

About

Yuling Zhou is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuling Zhou has authored 51 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuling Zhou's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Adipose Tissue and Metabolism (4 papers). Yuling Zhou is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Adipose Tissue and Metabolism (4 papers). Yuling Zhou collaborates with scholars based in China, Australia and United States. Yuling Zhou's co-authors include Craig S. McLachlan, Brett D. Hambly, Zhongchao Han, Wen Tan, Chen Wu, Yan Qiao, Dianke Yu, Kan Zhai, Dongxin Lin and Jiang Chang and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yuling Zhou

45 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuling Zhou China 16 229 138 103 84 77 51 599
Elizabeth V. Nguyen United States 16 303 1.3× 109 0.8× 115 1.1× 147 1.8× 59 0.8× 27 635
Fenghua Lan China 15 384 1.7× 110 0.8× 137 1.3× 123 1.5× 67 0.9× 62 712
Won‐Suk Jang South Korea 19 194 0.8× 156 1.1× 66 0.6× 130 1.5× 89 1.2× 32 662
Nicoletta Urbano Italy 16 148 0.6× 152 1.1× 92 0.9× 119 1.4× 43 0.6× 38 543
Jiaqing Pang United States 17 247 1.1× 107 0.8× 60 0.6× 77 0.9× 60 0.8× 37 804
Prasoon Agarwal Sweden 17 468 2.0× 108 0.8× 98 1.0× 48 0.6× 54 0.7× 35 829
Weifang Yu China 14 216 0.9× 80 0.6× 110 1.1× 77 0.9× 42 0.5× 30 427
Kun Xie China 16 317 1.4× 242 1.8× 100 1.0× 69 0.8× 94 1.2× 37 771
Rong Tan China 13 378 1.7× 147 1.1× 136 1.3× 80 1.0× 48 0.6× 33 661
Zhenling Wang China 16 298 1.3× 110 0.8× 120 1.2× 115 1.4× 71 0.9× 33 705

Countries citing papers authored by Yuling Zhou

Since Specialization
Citations

This map shows the geographic impact of Yuling Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuling Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuling Zhou more than expected).

Fields of papers citing papers by Yuling Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuling Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuling Zhou. The network helps show where Yuling Zhou may publish in the future.

Co-authorship network of co-authors of Yuling Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yuling Zhou. A scholar is included among the top collaborators of Yuling Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuling Zhou. Yuling Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Ruiying, et al.. (2024). Gut microbiota of miR‐30a‐5p‐deleted mice aggravate high‐fat diet‐induced hepatic steatosis by regulating arachidonic acid metabolic pathway. Clinical and Translational Medicine. 14(10). e70035–e70035. 2 indexed citations
3.
Deng, Lili, Yue Liu, Yuling Zhou, et al.. (2023). A Novel Fluorescence Sensor for Iodide Detection Based on the 1,3-Diaryl Pyrazole Unit with AIE and Mechanochromic Fluorescence Behavior. Molecules. 28(20). 7111–7111. 5 indexed citations
4.
Zeng, Liang, Yuling Zhou, Xiangyu Zhang, et al.. (2023). Copy number variations mediate major pathological response to induction chemo-immunotherapy in unresectable stage IIIA-IIIB lung cancer. Lung Cancer. 178. 134–142. 5 indexed citations
5.
Jiang, Wenjuan, Yuling Zhou, Liang Zeng, et al.. (2022). The efficacy and safety of albumin-bound paclitaxel plus carboplatin as neoadjuvant therapy for potentially resectable lung squamous cell carcinoma: a real-world retrospective cohort study. Translational Lung Cancer Research. 11(4). 647–655. 4 indexed citations
6.
Wei, Wei, Rong Wang, Yuling Zhou, et al.. (2022). Tumor Microbiome in Nasopharyngeal Carcinoma and Its Association With Prognosis. Frontiers in Oncology. 12. 859721–859721. 15 indexed citations
7.
8.
Liu, Qiaodan, Yujing Lin, Shunli Peng, et al.. (2021). Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma. Radiation Oncology. 16(1). 198–198. 5 indexed citations
9.
Alam, Sk. Kayum, Yongchang Zhang, Li Wang, et al.. (2021). DARPP-32 promotes ERBB3-mediated resistance to molecular targeted therapy in EGFR-mutated lung adenocarcinoma. Oncogene. 41(1). 83–98. 16 indexed citations
10.
Yan, Jinhua, Zhongbo Chen, Yumei Liang, et al.. (2020). Anti-CV2/CRMP5 antibody-positive paraneoplastic neurological syndromes with chronic intestinal pseudo-obstruction in a small-cell lung cancer patient: a case report and literature review. Journal of International Medical Research. 48(12). 1220774018–1220774018. 7 indexed citations
11.
12.
Zhou, Yuling, Analyn Lizaso, Xinru Mao, Nong Yang, & Yongchang Zhang. (2020). Novel AMBRA1-ALK fusion identified by next-generation sequencing in advanced gallbladder cancer responds to crizotinib: a case report. Annals of Translational Medicine. 8(17). 1099–1099. 5 indexed citations
13.
Li, Yan, Yan He, Yang Ruan, et al.. (2018). Pharmacological Blockade of Adenosine A2A but Not A1 Receptors Enhances Goal-Directed Valuation in Satiety-Based Instrumental Behavior. Frontiers in Pharmacology. 9. 393–393. 17 indexed citations
14.
Zhou, Rong, Shuya Zhang, Yuanyuan Ge, et al.. (2018). Adenosine A2A receptor antagonists act at the hyperoxic phase to confer protection against retinopathy. Molecular Medicine. 24(1). 41–41. 20 indexed citations
15.
Zhou, Yuling, Herbert F. Jelinek, Brett D. Hambly, & Craig S. McLachlan. (2017). Electrocardiogram QRS duration and associations with telomere length: A cross-sectional analysis in Australian rural diabetic and non-diabetic population. Journal of Electrocardiology. 50(4). 450–456. 5 indexed citations
16.
Han, Wei, Yuling Zhou, Rong Zhong, et al.. (2013). Functional Polymorphisms in FAS/FASL System Increase the Risk of Neuroblastoma in Chinese Population. PLoS ONE. 8(8). e71656–e71656. 27 indexed citations
17.
Zhou, Yuling, et al.. (2013). Synergistic effect of clinically used antibiotics and peptide antibiotics against Gram-positive and Gram-negative bacteria. Experimental and Therapeutic Medicine. 6(4). 1000–1004. 34 indexed citations
18.
Zhai, Kan, Xiaobo Tian, Chen Wu, et al.. (2012). Cytokine BAFF Gene Variation Is Associated with Survival of Patients with T-cell Lymphomas. Clinical Cancer Research. 18(8). 2250–2256. 10 indexed citations
19.
Hou, Xuwei, Lifang Wang, Ningfu Wang, et al.. (2007). The G501C polymorphism of oxidized LDL receptor gene [OLR-1] is associated with susceptibility and serum C-reactive protein concentration in Chinese essential hypertensives. Clinica Chimica Acta. 388(1-2). 200–203. 24 indexed citations
20.
Chen, Xiaoli, Jianhui Xu, Zhenping Chen, et al.. (2007). Interferon‐γ +874A/T and interleukin‐4 intron3 VNTR gene polymorphisms in Chinese patients with idiopathic thrombocytopenic purpura. European Journal Of Haematology. 79(3). 191–197. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth V. Nguyen Breakdown of academic impact, for papers by Fenghua Lan Breakdown of academic impact, for papers by Won‐Suk Jang Breakdown of academic impact, for papers by Nicoletta Urbano Breakdown of academic impact, for papers by Jiaqing Pang Breakdown of academic impact, for papers by Prasoon Agarwal Breakdown of academic impact, for papers by Weifang Yu Breakdown of academic impact, for papers by Kun Xie Breakdown of academic impact, for papers by Rong Tan Breakdown of academic impact, for papers by Zhenling Wang
Rankless by CCL
2026